Table 2.
All-cause mortality | CVD incidence | |||
---|---|---|---|---|
Independent predictor | RR | 95 % CI | RR | 95 % CI |
Model 1: Total cholesterol (per 1 mg/dL*) | 1.006 | 1.000,1.013 | 1.003 | 0.999,1.007 |
Model 2: HDL cholesterol (per 1 mg/dL) | 0.988 | 0.962,1.015 | 0.983 | 0.967,1.000 |
Model 3: LDL cholesterol (per 1 mg/dL) | 1.004 | 0.996,1.011 | 1.002 | 0.998.1.007 |
Model 4: non-HDL cholesterol (per 1 mg/dL) | 1.006 | 1.000,1.013 | 1.005 | 1.001,1.009 |
Model 5: Triglycerides (per 1 mg/dL) | 1.002 | 1.000,1.004 | 1.002 | 1.001,1.003 |
Model 5: Lipoprotein-a (per 1 mg/dL) | 1.004 | 0.994,1.015 | 1.003 | 0.997,1.010 |
Model 6: Apolipoprotein-A1 (per 1 mg/dL) | 0.991 | 0.978,1.004 | 0.992 | 0.985,1.000 |
Model 7: Apolipoprotein-B (per 1 mg/dL) | 1.004 | 0.997,1.012 | 1.002 | 0.998,1.007 |
Model 8: Total/HDL-cholesterol ratio (per 1 unit) | 1.169 | 0.978,1.387 | 1.216 | 1.092,1.354 |
Model 9: Apolipoprotein-B/-A1 ratio (per 1 unit) | 1.560 | 0.837,2.910 | 1.389 | 0.921,2.094 |
Model 10: Triglycerides/ HDL-cholesterol ratio (per 1 unit) | 1.038 | 1.001,1.077 | 1.055 | 1.031,1.078 |
All models were adjusted for age, sex, BMI, smoking habits, physical activity status, MedDietScore and history and pharmaceutical management of dyslipidemias, hypertension and diabetes, and family history of CVD at baseline examination. Results are presented as Relative Risk (RR) and 95 % Confidence Interval (CI)
*1 mg/dL corresponds to 0.0259 mmol/L for Total cholesterol, HDL cholesterol, LDL cholesterol, non-HDL cholesterol and to 0.0115 mmol/L for Triglycerides